Arbinoxa

Arbinoxa

Arbinoxa Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Deaths have been reported in children less than 2 years of age who were taking antihistamines, including carbinoxamine-containing drug products, therefore, carbinoxamine maleate is contraindicated in children younger than 2 years of age (see CONTRAINDICATIONS).

Antihistamines should be used with considerable caution in patients with: narrow angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Carbinoxamine maleate is effective for the symptomatic treatment of:
Seasonal and perennial allergic rhinitis.

Vasomotor rhinitis.

Allergic conjunctivitis due to inhalant allergens and foods.

Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.

Dermatographism.

As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Amelioration of the severity of allergic reactions to blood or plasma.

History

There is currently no drug history available for this drug.

Other Information

Carbinoxamine maleate is a histamine-H1 receptor blocking agent.

Each 5 mL (teaspoonful) of oral solution contains 4 mg carbinoxamine maleate and the following inactive ingredients: artificial bubble gum flavor, citric acid (anhydrous), glycerin, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate (hydrous) and sorbitol solution.

Carbinoxamine maleate is freely soluble in water. Its structure is:

Arbinoxa structure

2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N, N-dimethylethanamine (Z)-2-butenedioate (1:1)
C16H19ClN2O•C4H4O4
MW = 406.86

Arbinoxa Manufacturers


  • Hawthorn Pharmaceuticals, Inc.
    Arbinoxa (Carbinoxamine Maleate) Solution [Hawthorn Pharmaceuticals, Inc.]
  • Hawthorn Pharmaceuticals, Inc.
    Arbinoxa (Carbinoxamine Maleate) Tablet [Hawthorn Pharmaceuticals, Inc.]

Login To Your Free Account